Farber RH - Search Results

1

A pharmacokinetic evaluation of five H(1) antagonists after an oral and intravenous microdose to human subjects.

Madan A, O'Brien Z, Wen J, O'Brien C, Farber RH, Beaton G, Crowe P, Oosterhuis B, Garner RC, Lappin G, Bozigian HP. Madan A, et al. Among authors: farber rh. Br J Clin Pharmacol. 2009 Mar;67(3):288-98. doi: 10.1111/j.1365-2125.2008.03351.x. Br J Clin Pharmacol. 2009. PMID: 19523012 Free PMC article. Clinical Trial.

2

Single-Dose Study of a Corticotropin-Releasing Factor Receptor-1 Antagonist in Women With 21-Hydroxylase Deficiency.

Turcu AF, Spencer-Segal JL, Farber RH, Luo R, Grigoriadis DE, Ramm CA, Madrigal D, Muth T, O'Brien CF, Auchus RJ. Turcu AF, et al. Among authors: farber rh. J Clin Endocrinol Metab. 2016 Mar;101(3):1174-80. doi: 10.1210/jc.2015-3574. Epub 2016 Jan 11. J Clin Endocrinol Metab. 2016. PMID: 26751191 Free PMC article. Clinical Trial.

3

Crinecerfont Lowers Elevated Hormone Markers in Adults With 21-Hydroxylase Deficiency Congenital Adrenal Hyperplasia.

Auchus RJ, Sarafoglou K, Fechner PY, Vogiatzi MG, Imel EA, Davis SM, Giri N, Sturgeon J, Roberts E, Chan JL, Farber RH. Auchus RJ, et al. Among authors: farber rh. J Clin Endocrinol Metab. 2022 Feb 17;107(3):801-812. doi: 10.1210/clinem/dgab749. J Clin Endocrinol Metab. 2022. PMID: 34653252 Free PMC article. Clinical Trial.

4

Post-bedtime dosing with indiplon in adults and the elderly: results from two placebo-controlled, active comparator crossover studies in healthy volunteers.

Farber RH, Burke PJ. Farber RH, et al. Curr Med Res Opin. 2008 Mar;24(3):837-46. doi: 10.1185/030079908X273327. Epub 2008 Feb 6. Curr Med Res Opin. 2008. PMID: 18257978 Clinical Trial.

5

Pharmacokinetics of Budesonide Oral Suspension in Children and Adolescents With Eosinophilic Esophagitis.

Gupta SK, Hill M, Vitanza JM, Farber RH, Desai NK, Williams J, Song IH. Gupta SK, et al. Among authors: farber rh. J Pediatr Gastroenterol Nutr. 2022 Aug 1;75(2):186-191. doi: 10.1097/MPG.0000000000003482. Epub 2022 Jun 6. J Pediatr Gastroenterol Nutr. 2022. PMID: 35666852 Free PMC article. Clinical Trial.

6

Clinical development of valbenazine for tics associated with Tourette syndrome.

Farber RH, Angelov A, Kim K, Carmack T, Thai-Cuarto D, Roberts E. Farber RH, et al. Expert Rev Neurother. 2021 Apr;21(4):393-404. doi: 10.1080/14737175.2021.1898948. Epub 2021 Apr 1. Expert Rev Neurother. 2021. PMID: 33682568 Review.

7

Long-term nightly treatment with indiplon in adults with primary insomnia: results of a double-blind, placebo-controlled, 3-month study.

Scharf MB, Black J, Hull S, Landin R, Farber R. Scharf MB, et al. Sleep. 2007 Jun;30(6):743-52. doi: 10.1093/sleep/30.6.743. Sleep. 2007. PMID: 17580596 Free PMC article. Clinical Trial.

8

Efficacy and tolerability of indiplon in transient insomnia.

Rosenberg R, Roth T, Scharf MB, Lankford DA, Farber R. Rosenberg R, et al. J Clin Sleep Med. 2007 Jun 15;3(4):374-9. J Clin Sleep Med. 2007. PMID: 17694726 Free PMC article. Clinical Trial.

9

Efficacy and safety of as-needed, post bedtime dosing with indiplon in insomnia patients with chronic difficulty maintaining sleep.

Roth T, Zammit GK, Scharf MB, Farber R. Roth T, et al. Sleep. 2007 Dec;30(12):1731-8. doi: 10.1093/sleep/30.12.1731. Sleep. 2007. PMID: 18246982 Free PMC article. Clinical Trial.

10

Efficacy and tolerability of indiplon in older adults with primary insomnia.

Walsh JK, Moscovitch A, Burke J, Farber R, Roth T. Walsh JK, et al. Sleep Med. 2007 Nov;8(7-8):753-9. doi: 10.1016/j.sleep.2006.12.006. Epub 2007 Sep 6. Sleep Med. 2007. PMID: 17825616 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

19 results

Search Page

Filters